Cardiac Pathways To Launch Chilli Ablation Device With Ultrasound System
This article was originally published in The Gray Sheet
Cardiac Pathway intends to launch both its second-generation Chillirpm cooled ablation catheter and Real-time Position Management (RPM) ultrasound tracking system at the upcoming scientific sessions of the North American Society of Pacing and Electrophysiology. The medical specialty meeting is scheduled for May 16-20 in Washington, D.C.
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.